These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 16809479

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.
    Liu S, Veilleux A, Zhang L, Young A, Kwok E, Laliberté F, Chung C, Tota MR, Dubé D, Friesen RW, Huang Z.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):846-54. PubMed ID: 15901792
    [Abstract] [Full Text] [Related]

  • 25. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors.
    Rutten K, Prickaerts J, Hendrix M, van der Staay FJ, Sik A, Blokland A.
    Eur J Pharmacol; 2007 Mar 08; 558(1-3):107-12. PubMed ID: 17207788
    [Abstract] [Full Text] [Related]

  • 26. The effects of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on T-cell-related cytokine production in vitro and in vivo.
    Yamamoto S, Sugahara S, Naito R, Ichikawa A, Ikeda K, Yamada T, Shimizu Y.
    Eur J Pharmacol; 2006 Jul 10; 541(1-2):106-14. PubMed ID: 16780833
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM, Xie QM, Tang HF, Sun JG, Deng JF, Chen JQ, Yang SY.
    Eur J Pharmacol; 2006 Oct 10; 547(1-3):125-35. PubMed ID: 16956605
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis.
    Morini M, Roccatagliata L, Dell'Eva R, Pedemonte E, Furlan R, Minghelli S, Giunti D, Pfeffer U, Marchese M, Noonan D, Mancardi G, Albini A, Uccelli A.
    J Neuroimmunol; 2004 Mar 10; 148(1-2):146-53. PubMed ID: 14975595
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.
    Loher F, Schmall K, Freytag P, Landauer N, Hallwachs R, Bauer C, Siegmund B, Rieder F, Lehr HA, Dauer M, Kapp JF, Endres S, Eigler A.
    J Pharmacol Exp Ther; 2003 May 10; 305(2):549-56. PubMed ID: 12606674
    [Abstract] [Full Text] [Related]

  • 34. Ribavirin reduces clinical signs and pathological changes of experimental autoimmune encephalomyelitis in Dark Agouti rats.
    Milicevic I, Pekovic S, Subasic S, Mostarica-Stojkovic M, Stosic-Grujicic S, Medic-Mijacevic L, Pejanovic V, Rakic L, Stojiljkovic M.
    J Neurosci Res; 2003 Apr 15; 72(2):268-78. PubMed ID: 12672002
    [Abstract] [Full Text] [Related]

  • 35. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats.
    Sakura M, Masuda H, Matsuoka Y, Yokoyama M, Kawakami S, Kihara K.
    BJU Int; 2009 Jan 15; 103(2):264-9. PubMed ID: 18710439
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The novel phosphodiesterase 4 inhibitor, CI-1044, inhibits LPS-induced TNF-alpha production in whole blood from COPD patients.
    Ouagued M, Martin-Chouly CA, Brinchault G, Leportier-Comoy C, Depincé A, Bertrand C, Lagente V, Belleguic C, Pruniaux MP.
    Pulm Pharmacol Ther; 2005 Jan 15; 18(1):49-54. PubMed ID: 15607127
    [Abstract] [Full Text] [Related]

  • 40. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I, Ballerini C, Biagioli T, Biamonte F, Bellucci A, Rosi MC, Grossi C, Massacesi L, Casamenti F.
    Exp Neurol; 2008 May 15; 211(1):214-26. PubMed ID: 18346732
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.